Company Overview and News

 
IPOs This Week: 5/21/18

2018-05-21 seekingalpha
This weeks breakdown includes 2 Chinese IPOs and 4 biopharma companies. The remaining 2 IPOs focus on payment processing and financing.

 
CLPS IPO: It Is Undervalued, But I Am Not A Buyer

2018-05-18 seekingalpha
I don’t appreciate that the parent company is located in Cayman Islands. The fact that the business is Chinese does not help either.

 
Zacks Investment Ideas feature highlights: Match Group, InterActive, Facebook, ANGI and Homeservices

2018-05-11 zacks
Chicago, IL – May 11, 2018 – Today, Zacks Investment Ideas feature highlights Features: Match Group (MTCH - Free Report) , InterActive Corp (IAC - Free Report) , Facebook (FB - Free Report) and ANGI Homeservices Inc (ANGI - Free Report) .

 
Exelixis, Applied Optoelectronics and Nvidia as Zacks Bull and Bear of the Day

2018-05-11 zacks
Chicago, IL – May 11, 2018 – Zacks Equity Research highlights Exelixis (EXEL - Free Report) as the Bull of the Day and Applied Optoelectronics (AAOI - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Nvidia Corporation (NVDA - Free Report) .

 
Zacks Value Investor Highlights: Apple, Amazon, Alphabet, China Life Insurance and Jacobs Engineering

2018-05-11 zacks
Chicago, IL – May 11, 2018 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:

 
Sino-Ocean first to swoop on Anbang assets since state takeover

2018-05-10 scmp
News coincides with founder Wu Xiaohui’s conviction earlier in the day to 18 years in prison with US$1.65b worth of his personal properties confiscated

 
Insurers lead Hong Kong stocks higher in morning session

2018-05-08 scmp
Hong Kong stocks began the morning session higher on Tuesday, driven by gains in insurers and overnight advances in Wall Street as investors await a decision by the US to reimpose sanctions on Iran.

 
Is it gloom or boom, Dr Doom? Marc Faber on US-China trade war, the Japan trap and why finance is more vulnerable than in 2007

2018-05-06 scmp
With jitters over the world economy growing, Marc Faber’s profile faded just when his contrarian ideas might be needed most. Now ‘Dr Doom’ is back – and he has some advice for the China bulls and bears

1
This Week’s Top 10 Stocks Under $20

2018-05-02 investorplace
Here at Zacks, we don’t generally classify stocks as “cheap” or “expensive”, and rather than looking at the stock’s face value, we have a system that puts an emphasis on earnings estimate revisions to find stocks that will hopefully be winners for investors.

2
Top 10 Stocks Under $20

2018-05-02 zacks
Here at Zacks, we don’t generally classify stocks as “cheap” or “expensive”, and rather than looking at the stock’s face value, we have a system that puts an emphasis on earnings estimate revisions to find stocks that will hopefully be winners for investors.

 
Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Caterpillar, Cree, GrubHub, Intel, 3M, MetLife, Verizon and More

2018-04-25 247wallst
Stocks sold off handily on Tuesday as the 3% mark on the 10-year Treasury yield was challenged, but stocks were trying to stage a small rally on Wednesday morning. Some investors have reconsidered what the nine-year bull market may bring in 2018 and beyond. It has become clear that the multiyear trend of buying pullbacks is now more vulnerable to sellers, volatility and each major news headline. Many investors are finding it harder to decide how they want their assets positioned for the longer term.

 
Zacks Investment Ideas feature highlights: Phillip Morris International, Altria and British American Tobacco

2018-04-20 zacks
Chicago, IL – April 20, 2018 – Today, Zacks Investment Ideas feature highlights Features: Phillip Morris International (PM - Free Report) , Altria (MO - Free Report) and British American Tobacco (BTI - Free Report) .

1
The Zacks Analyst Blog Highlights: IBM, McDonald's, Gilead, Phillips 66 and Lam Research

2018-04-20 zacks
Chicago, IL – April 20, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include IBM (IBM - Free Report) , McDonald's (MCD - Free Report) , Gilead (GILD - Free Report) , Phillips 66 (PSX - Free Report) and Lam Research (LRCX - Free Report) .

 
The Zacks Analyst Blog Highlights: Flotek Industries, Nine Energy Service, Baytex Energy, Mammoth Energy Services and CNOOC

2018-04-20 zacks
Chicago, IL – April 20, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Flotek Industries, Inc. (FTK - Free Report) , Nine Energy Service, Inc. (NINE - Free Report) , Baytex Energy Corp. (BTE - Free Report) , Mammoth Energy Services, Inc.

 
The Zacks Analyst Blog Highlights: Etsy, eBay, Amazon and PetMed Express

2018-04-20 zacks
Chicago, IL – April 20, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Etsy (ETSY - Free Report) , eBay (EBAY - Free Report) , Amazon (AMZN - Free Report) and PetMed Express (PETS - Free Report) .

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...